Vanderbilt Research Trending Archives
New target to stop Ebola
May. 21, 2018—A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members.
Deerfield Management, Vanderbilt University announce launch of Ancora Innovation
Mar. 28, 2018—Deerfield Management and Vanderbilt University announced March 28 the launch of Ancora Innovation, LLC (“Ancora”), a Deerfield company that will support Vanderbilt’s innovative life science research and leverage Deerfield’s expertise in accelerating state-of-the-art drug development.
Nine new endowed chair recipients honored
Mar. 5, 2018—Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28.
Saline use on decline at Vanderbilt following landmark studies
Feb. 27, 2018—Vanderbilt University Medical Center is encouraging its medical providers to stop using saline as intravenous fluid therapy for most patients, a change provoked by two companion landmark studies released Feb. 27 that are anticipated to improve survival and decrease kidney complications.
Opioid use increases risk of serious infections
Feb. 12, 2018—Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don’t use opioids.
‘Smart cane’ could one day help flag gait problems, falling risks more quickly
Feb. 12, 2018—Falling is no joke when you're a senior citizen or have other balance issues. Vanderbilt engineers are working on a 'smart cane' that could help physical therapists spot and treat problems sooner.
Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment
Jan. 8, 2018—Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.
Study seeks to reduce opioid use for chronic pain
Nov. 30, 2017—Kristin Archer, PhD, DPT, associate professor and vice chair of Orthopaedics and Rehabilitation, will serve as principal investigator at Vanderbilt University Medical Center (VUMC) for a clinical trial that is examining strategies for reducing opioid use among patients with chronic pain.
‘Mind’s eye blink’ proves ‘paying attention’ is not just a figure of speech
Nov. 21, 2017—Vanderbilt psychologists have discovered that when you shift your attention from one place to another, your brain 'blinks'—or experiences momentary gaps in perception.
15 faculty members elected as AAAS fellows
Nov. 20, 2017—Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.
Vanderbilt leads international effort to develop universal flu vaccine
Oct. 26, 2017—Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.
Cell signals that trigger wound healing are surprisingly complex
Oct. 3, 2017—Vanderbilt scientists have taken an important step toward understanding the way in which injured cells trigger wound healing, an insight essential for improving treatments of all types of wounds.
